(225 ILCS 120/58)
(Section scheduled to be repealed on January 1, 2023)
It is unlawful for a person to perform or cause the performance of or aid and abet any of the following acts:
(1) Failure to obtain a license in accordance with
this Act or operating without a valid license when a license is required by this Act.
(2) If the requirements of subsection (a) of Section
56 of this Act are applicable and are not met, the purchasing or otherwise receiving of a prescription drug from a pharmacy.
(3) If licensure is required pursuant to subsection
(b) of Section 56 of this Act, the sale, distribution, or transfer of a prescription drug to a person that is not authorized under the law of the jurisdiction in which the person receives the prescription drug to receive the prescription drug.
(4) Failure to deliver prescription drugs to
specified premises, as required by subsection (c) of Section 56 of this Act.
(5) Accepting payment or credit for the sale of
prescription drugs in violation of subsection (e) of Section 56 of this Act.
(6) Failure to maintain or provide pedigrees as
(7) Failure to obtain, pass, or authenticate a
pedigree as required by this Act.
(8) Providing the Department or any federal official
with false or fraudulent records or making false or fraudulent statements regarding any matter within the provisions of this Act.
(9) Obtaining or attempting to obtain a prescription
drug by fraud, deceit, or misrepresentation or engaging in misrepresentation or fraud in the distribution of a prescription drug.
(10) The manufacture, repacking, sale, transfer,
delivery, holding, or offering for sale of any prescription drug that is adulterated, misbranded, counterfeit, suspected of being counterfeit, or that has otherwise been rendered unfit for distribution, except for the wholesale distribution by manufacturers of a prescription drug that has been delivered into commerce pursuant to an application approved under federal law by the FDA.
(11) The adulteration, misbranding, or counterfeiting
of any prescription drug, except for the wholesale distribution by manufacturers of a prescription drug that has been delivered into commerce pursuant to an application approved under federal law by the FDA.
(12) The receipt of any prescription drug that is
adulterated, misbranded, stolen, obtained by fraud or deceit, counterfeit, or suspected of being counterfeit and the delivery or proffered delivery of such drug for pay or otherwise.
(13) The alteration, mutilation, destruction,
obliteration, or removal of the whole or any part of the labeling of a prescription drug or the commission of any other act with respect to a prescription drug that results in the prescription drug being misbranded. The acts prohibited in this Section do not include the obtaining or the attempt to obtain a prescription drug for the sole purpose of testing the prescription drug for authenticity performed by a prescription drug manufacturer or the agent of a prescription drug manufacturer.
(Source: P.A. 95-689, eff. 10-29-07